This study aims to perform a quantitative synthesis of research literature yielding empirical evidence of the efficacy of System Training for Emotional Predictability and Problem Solving (STEPPS; Blum, Bartels, John and Pfohl, 2002) in the treatment of Borderline Personality Disorder (BPD). A search in the SCOPUS and PsychInfo databases yielded 7 studies (4 longitudinal, «open label» and 3 RCT), which provided data concerning the efficacy of STEPPS in reducing BPD symptom severity, as well as in reducing self-report depressive and general psychiatric symptoms. Although heterogeneity statistics were highly significant, cumulative effect size estimates (Cohen d) evidence high efficacy of STEPPS in reducing the severity of both self-reported (dw= 0.91) and observer-rated (dw= 1.24) BPD symptoms, as well as self-reported depressive symptoms (dw= 0.89); STEPPS showed moderate cumulative efficacy in reducing self-reported general psychiatric symptoms (dw= 0.65). Although the number of available studies on STEPPS efficacy was at best moderate, the results of our meta-analysis support the clinical utility of STEPPS in treating BPD.
Empirical evidence of the efficacy of System Training for Emotional Predictability and Problem Solving (STEPPS) in the treatment of borderline personality disorder: A meta-analysis of published research
Somma A.Primo
;Borroni S.;Maffei C.Penultimo
;Fossati A.
Ultimo
2014-01-01
Abstract
This study aims to perform a quantitative synthesis of research literature yielding empirical evidence of the efficacy of System Training for Emotional Predictability and Problem Solving (STEPPS; Blum, Bartels, John and Pfohl, 2002) in the treatment of Borderline Personality Disorder (BPD). A search in the SCOPUS and PsychInfo databases yielded 7 studies (4 longitudinal, «open label» and 3 RCT), which provided data concerning the efficacy of STEPPS in reducing BPD symptom severity, as well as in reducing self-report depressive and general psychiatric symptoms. Although heterogeneity statistics were highly significant, cumulative effect size estimates (Cohen d) evidence high efficacy of STEPPS in reducing the severity of both self-reported (dw= 0.91) and observer-rated (dw= 1.24) BPD symptoms, as well as self-reported depressive symptoms (dw= 0.89); STEPPS showed moderate cumulative efficacy in reducing self-reported general psychiatric symptoms (dw= 0.65). Although the number of available studies on STEPPS efficacy was at best moderate, the results of our meta-analysis support the clinical utility of STEPPS in treating BPD.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.